Nature Communications (Feb 2021)
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
Abstract
REACT-2 is a large-scale community study of SARS-CoV-2 seroprevalence in England. Here, the authors estimate that 6% of adults in England had been infected by mid-July 2020, with health and long-term care workers and those of Black or South Asian ethnicity disproportionately affected.